Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...
About Evrysdi Evrysdi is an SMN2-splicing modifier designed to increase functional SMN protein production. With the introduction of a new tablet formulation, Evrysdi now offers an alternative ...
Aquestive Therapeutics (AQST) announced that multiple presentations highlighting results from the investigational use of Anaphylm epinephrine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results